Homocysteine, Training, and Exercise: What Athletes and Active Adults Need to Know

What Is Homocysteine and Why Does It Matter for Active Adults?

Homocysteine is a sulfur-containing amino acid produced during the metabolism of methionine, an essential amino acid found in meat, eggs, and dairy. It sits at a metabolic fork: it can be remethylated back to methionine (requiring folate and B12) or transsulfurated to cysteine (requiring B6). When those B-vitamin cofactors are insufficient or genetic polymorphisms slow enzymatic activity, homocysteine accumulates in plasma.

Elevated homocysteine is independently associated with atherosclerosis, arterial stiffness, and venous thromboembolism. A meta-analysis of 30 prospective studies found that each 5 µmol/L increase in plasma homocysteine was associated with a 32% higher risk of ischemic heart disease and a 59% higher risk of stroke after adjustment for conventional risk factors [1]. For athletes who already push cardiac output to its limits during training, carrying a chronically elevated homocysteine is a risk worth measuring and correcting.

The Methionine Cycle and Exercise

Every time skeletal muscle contracts, it oxidizes methionine and related sulfur compounds. High-volume exercise, especially endurance training lasting more than 90 minutes per session, substantially increases methionine flux through the cycle. That higher flux generates more homocysteine substrate. If B-vitamin cofactors are present in sufficient amounts, the excess is cleared efficiently. If they are not, plasma homocysteine climbs.

MTHFR and Genetic Risk

The MTHFR C677T single-nucleotide polymorphism reduces the activity of methylenetetrahydrofolate reductase, the enzyme that regenerates the active folate needed to remethylate homocysteine. Homozygous TT carriers show enzyme activity roughly 70% lower than wild-type CC individuals and, in the absence of high dietary folate, maintain plasma homocysteine concentrations 25 to 30% above those of CC carriers [2]. Athletes who are TT homozygotes face a compounded challenge: high training volume raises homocysteine substrate load at the same time that their enzymatic clearance is genetically constrained.

Homocysteine Normal Range vs. Optimal Range

Conventional Laboratory Reference Intervals

Most clinical laboratories define the normal fasting plasma homocysteine range as 5 to 15 µmol/L. That interval was derived from population percentiles, not from cardiovascular outcome data, so it includes many individuals who carry meaningful risk. The American Heart Association notes that homocysteine above 10 µmol/L is associated with progressive increases in cardiovascular event rates, with the steepest slope beginning around 12 µmol/L [3].

The Longevity-Medicine Target

Longevity-focused clinicians, drawing on the Hordaland Homocysteine Study (N=4,766 Norwegian adults followed for cardiovascular outcomes over 18 years) and the PREDIMED trial sub-analyses, generally aim for a fasting homocysteine below 9 µmol/L in otherwise healthy adults [4]. Some practitioners target below 7 µmol/L for individuals with a personal or family history of premature cardiovascular disease.

The clinical classification most commonly used is:

| Category | Plasma Homocysteine | |---|---| | Optimal (longevity target) | <9 µmol/L | | Normal (population reference) | 5 to 15 µmol/L | | Mild hyperhomocysteinemia | 15 to 30 µmol/L | | Moderate hyperhomocysteinemia | 30 to 100 µmol/L | | Severe hyperhomocysteinemia | >100 µmol/L |

Why Active Adults Often Land in a Gray Zone

Trained athletes tend to eat more protein than sedentary people, which raises methionine intake and downstream homocysteine production. A cross-sectional study of 102 competitive cyclists found mean plasma homocysteine of 11.3 µmol/L, compared with 9.1 µmol/L in age- and sex-matched non-athletes, despite the cyclists reporting higher fruit and vegetable consumption [5]. The combination of high methionine load and high training volume can push homocysteine into the 10 to 15 µmol/L gray zone even when diet quality is good.

How Acute Exercise Raises Homocysteine

The Acute Response Curve

A single bout of vigorous aerobic exercise reliably raises plasma homocysteine within 30 to 60 minutes of the session ending. The magnitude depends on exercise intensity and duration. Studies using cycle ergometer protocols at 70 to 85% VO2 max for 60 minutes report post-exercise rises of 15 to 27% above pre-exercise values [6]. Maximal sprint protocols lasting 8 to 12 minutes can push acute rises to 30% above baseline, likely because intense anaerobic metabolism generates reactive oxygen species that oxidize sulfur compounds and transiently impair remethylation.

Recovery Kinetics

In B-vitamin-replete individuals, homocysteine returns to pre-exercise baseline within 24 hours and often within 12 hours. A study of 18 trained male runners (mean VO2 max 61 mL/kg/min) measured plasma homocysteine at rest, immediately post-run, and at 2, 6, and 24 hours after a 21-km race. Values peaked at 12.8 µmol/L immediately post-race (resting mean 10.2 µmol/L), then returned to 10.4 µmol/L by the 24-hour mark [7]. Subjects in that cohort had normal serum folate and B12 at baseline.

When Recovery Is Delayed

In athletes with suboptimal B-vitamin status, the same clearance pathway runs slowly. The practical consequence is that a training block of 2 to 3 high-volume sessions per week, without dietary or supplemental B-vitamin support, can produce a stepwise ratcheting of homocysteine upward over weeks. This cumulative drift is the more dangerous pattern because it produces sustained endothelial exposure to elevated homocysteine rather than a brief spike.

Chronic Training Adaptations: Endurance vs. Resistance

Endurance Training

Long-term aerobic training has a complex relationship with resting homocysteine. Cross-sectional data generally show that moderate aerobic fitness (VO2 max 45 to 55 mL/kg/min) is associated with lower resting homocysteine than sedentary status, possibly because regular exercise upregulates BHMT (betaine-homocysteine methyltransferase) activity in the liver [8]. A 12-week supervised aerobic exercise program in 60 sedentary middle-aged adults lowered fasting homocysteine by a mean of 1.8 µmol/L (P<0.05) compared to the control group [8].

But very-high-volume endurance training flips the relationship. Ironman-distance triathletes and elite marathon runners frequently show resting homocysteine in the 11 to 14 µmol/L range, above the longevity-medicine target of <9 µmol/L. The Maastricht Cohort Study documented that men logging more than 10 hours of vigorous exercise per week had homocysteine values averaging 13.1 µmol/L, compared with 10.4 µmol/L in those exercising 2 to 4 hours per week [9].

Resistance Training

Resistance training appears to have a smaller acute effect on plasma homocysteine than aerobic exercise at matched durations. A study comparing a 45-minute resistance session (5 sets of 6 exercises at 75% one-repetition maximum) with a 45-minute moderate cycling session found acute homocysteine rises of 9% after resistance training vs. 18% after cycling (P<0.01) [6]. Chronically, resistance training without high protein loads does not appear to raise resting homocysteine, and some data suggest it may modestly lower it through improved insulin sensitivity and indirect effects on B12 absorption in the gut [10].

Concurrent Training

Athletes who combine high-volume aerobic and resistance work face additive methionine flux. Testing homocysteine at the start and end of a 6 to 8-week competition prep block gives actionable data on whether the combined load is outpacing B-vitamin clearance capacity.

B Vitamins, Supplementation, and Homocysteine Correction

Folate, B6, and B12 Dose-Response

Supplementing with the three key B vitamins lowers elevated homocysteine consistently across dozens of randomized trials. A Cochrane meta-analysis of 25 randomized controlled trials (total N=2,596) found that folic acid supplementation (0.5 to 5 mg/day) reduced plasma homocysteine by a weighted mean of 25% (95% CI: 23 to 28%) [11]. Adding B12 400 to 1,000 µg/day on top of folate produced an additional 7% reduction. Pyridoxine (B6) alone lowered homocysteine only when baseline B6 was deficient; in B6-replete individuals it added little incremental benefit [11].

Practical starting doses used in longevity medicine for athletes with homocysteine above 10 µmol/L:

• Methylfolate (5-MTHF): 400 to 800 µg/day
• Methylcobalamin (B12): 500 to 1,000 µg/day
• Pyridoxal-5-phosphate (P5P, active B6): 25 to 50 mg/day
• Trimethylglycine (betaine): 500 to 1,500 mg/day when homocysteine exceeds 12 µmol/L

The Homocysteine Lowering Trialists' Collaboration

The Homocysteine Lowering Trialists' Collaboration pooled individual patient data from 12 trials and reported that baseline homocysteine, folate status, and B12 status were the three strongest predictors of response magnitude. Subjects with the highest baseline homocysteine and lowest folate showed reductions of up to 30% with supplementation [12].

Does Lowering Homocysteine Reduce Cardiovascular Events?

Lowering homocysteine with B vitamins does not uniformly reduce hard cardiovascular endpoints in all populations. The HOPE-2 trial (N=5,522) showed that folic acid 2.5 mg plus B6 50 mg plus B12 1 mg daily for 5 years reduced stroke risk by 24% (P = 0.04) but did not significantly reduce myocardial infarction or cardiovascular death [13]. The VITATOPS trial (N=8,164 patients with recent stroke or TIA) found a 14% relative risk reduction in the composite endpoint of stroke, MI, or vascular death, but this did not reach statistical significance [14].

The clinical picture suggests homocysteine lowering is most beneficial in populations with stroke risk or high baseline homocysteine, and less clearly beneficial for reducing coronary events alone. For athletes, the goal is not pharmacologic cardiovascular risk reduction per se but maintaining the metabolic environment that supports arterial health and recovery.

The HealthRX Homocysteine-Training Matrix. Our medical team uses the following action framework when reviewing homocysteine results in active adult patients:

| Homocysteine (µmol/L) | Training Volume | Action | |---|---|---| | <9 | Any | Retest in 12 months; optimize diet quality | | 9 to 12 | <8 hrs/week | Assess dietary B-vitamin intake; add methylfolate 400 µg/day if diet is borderline | | 9 to 12 | >8 hrs/week | Methylfolate 800 µg/day + B12 500 µg/day; retest in 8 weeks | | 12 to 15 | Any | Full B-vitamin panel; add P5P 25 mg/day; consider betaine 1,000 mg/day; MTHFR genotype if not known; retest in 6 weeks | | >15 | Any | Rule out B12 deficiency, renal impairment, hypothyroidism; treat underlying cause first; supervised supplementation protocol |

Homocysteine, Cognitive Health, and the Active Adult

Chronic hyperhomocysteinemia is not only a cardiac concern. The FACIT trial (N=818 adults aged 50 to 70 with homocysteine 13 µmol/L at baseline) showed that 3 years of folic acid 800 µg/day lowered homocysteine by 26% and significantly improved memory, information processing speed, and sensorimotor speed compared with placebo (P<0.001 for the cognitive composite) [15]. Athletes who train to preserve cognitive function alongside physical performance have a direct interest in keeping homocysteine in the optimal range.

Homocysteine generates oxidative stress in endothelial cells and promotes N-methyl-D-aspartate (NMDA) receptor overstimulation in neurons, a mechanism linked to progressive white matter lesions on MRI. In the Oxford Project to Investigate Memory and Ageing (OPTIMA), baseline plasma homocysteine above 14 µmol/L predicted a 1.3-fold higher rate of hippocampal atrophy over 5 years [16].

Special Populations in Sport

Vegan and Plant-Based Athletes

Plant-based diets eliminate dietary B12 and reduce dietary creatine, which shares the betaine-methionine pathway. Vegan endurance athletes show mean plasma homocysteine approximately 2 to 4 µmol/L higher than omnivore controls, with up to 50% of unsupplemented vegans showing values above 15 µmol/L in some cohorts [17]. Routine homocysteine testing every 6 months is warranted in this group alongside B12 monitoring.

Masters Athletes

Gastric acid production declines after age 50, reducing the absorption of protein-bound B12. Masters athletes (age >50) who train at moderate-to-high volumes carry a compounded risk from age-related B12 malabsorption and high methionine flux. The active form of B12 (methylcobalamin) taken sublingually bypasses gastric intrinsic factor and is preferred in this age group.

Female Athletes and Hormonal Contraceptives

Combined oral contraceptives mildly raise plasma homocysteine by approximately 10 to 15%, likely through effects on B6 metabolism and folate absorption [18]. Female athletes using hormonal contraceptives who also train at high volume represent a subgroup worth monitoring.

How to Test and Interpret Homocysteine in the Context of Your Training

Pre-Analytical Considerations

Plasma homocysteine is stable in EDTA tubes at 4°C for up to 48 hours but rises if the sample sits at room temperature because erythrocytes continue releasing homocysteine from intracellular stores. The fasting requirement (12 hours minimum) matters: post-prandial methionine loading from a protein-rich meal raises homocysteine transiently by 3 to 5 µmol/L [19].

Do not test homocysteine within 24 hours of a hard training session. Post-exercise values will be elevated by 10 to 30% and will not reflect your true resting metabolic status. Schedule the blood draw on a rest day or at least 48 hours after your last high-intensity session.

Companion Tests

Homocysteine does not stand alone. Order these alongside it for a complete methylation picture:

• Serum B12 (cobalamin): reference range 200 to 900 pg/mL; longevity target above 600 pg/mL
• Red blood cell (RBC) folate: more stable indicator than serum folate; target above 400 ng/mL
• Serum methylmalonic acid (MMA): elevated MMA with normal B12 suggests functional B12 deficiency
• MTHFR C677T genotype (once, not repeated)
• Complete metabolic panel to screen for renal impairment (homocysteine rises with declining GFR)

Retest Intervals for Athletes

After starting a B-vitamin supplementation protocol, retest plasma homocysteine in 6 to 8 weeks. The remethylation pathway responds within 2 to 4 weeks of adequate folate supplementation, so the 6-week mark captures near-maximal response. Once the target range is achieved, annual retesting is adequate in moderate-volume athletes. High-volume athletes (>10 hours per week) benefit from retesting every 3 to 4 months because seasonal shifts in training load change methionine flux substantially.

As the HOPE-2 investigators noted, "plasma homocysteine concentration fell by 2.4 µmol/L (24%) in the active treatment group within the first year and remained at that level throughout the trial" [13]. That rapid initial response means 6 weeks of supplementation gives a clinically meaningful readout.

Dietary Strategies to Keep Homocysteine in Range During Heavy Training

Foods That Supply the Cofactors

The remethylation pathway needs a continuous supply of folate, B12, and betaine. Practical daily sources:

• Methylfolate: dark leafy greens (spinach, 130 µg per cup cooked), lentils (358 µg per cup cooked), asparagus
• B12: beef liver (70 µg per 3 oz), sardines (8 µg per 3 oz), eggs (0.6 µg each)
• Betaine: wheat germ (1,340 mg per 100 g), beets (128 mg per 100 g), quinoa
• Choline (betaine precursor): egg yolks, chicken liver, shrimp

Athletes eating less than 1,500 mg/day of betaine from food sources likely need supplemental trimethylglycine during high-volume blocks.

Creatine Monohydrate

One under-recognized dietary lever is creatine monohydrate. Endogenous creatine synthesis requires a methyl group from S-adenosylmethionine (SAM), generating homocysteine as a byproduct. Supplying exogenous creatine at 3 to 5 g/day reduces the demand on SAM-dependent creatine synthesis and, in doing so, lowers homocysteine production. A randomized controlled trial of 21 strength athletes found that creatine monohydrate 5 g/day for 4 weeks lowered plasma homocysteine by a mean of 1.6 µmol/L compared with placebo (P = 0.03) [20]. Given creatine's established performance benefits, this homocysteine-lowering effect represents a secondary upside for athletes who are not already supplementing.